tirzepatide diabetes trial A 72-week compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the GLP-1 medications linked to black_crow_do_not_cross_sell Size:32G (0.23mm) 5/32in (4mm) | 100/Box

tirzepatide diabetes trial A 72-week compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the GLP-1 medications linked to black_crow_do_not_cross_sell Size:32G (0.23mm) 5/32in (4mm) | 100/Box

GLP-1 medications linked to reduced progression of several cancers., Medications originally developed to treat type 2 diabetes and obesity may have another surprising benefit. Cleveland Clinic ...

This is standard across nearly all compounded GLP-1 providers, since insurance companies do not cover compounded medications

black_crow_do_not_cross_sell

Size:32G (0.23mm) 5/32in (4mm) | 100/Box

Most common side effects were mild to moderate digestive issues, more frequent at higher doses